Concept:
von Willebrand Disease (vWD) is the most common inherited bleeding disorder, characterized by quantitative or qualitative defects in von Willebrand Factor (vWF).
vWF serves two vital physiological functions: mediating platelet adhesion to subendothelial collagen during primary hemostasis and acting as a carrier chaperone protein for Factor VIII (FVIII) to prevent its rapid degradation.
Explanation:
• Type 1 vWD is an autosomal dominant disorder characterized by a mild to moderate quantitative deficiency of structurally normal vWF, accounting for approximately 70% to 80% of all clinical cases, and generally follows a mild mucosal bleeding phenotype.
• Type 2 vWD represents qualitative (functional) defects in vWF and is subclassified into types 2A, 2B, 2M, and 2N, presenting with moderate mucocutaneous bleeding severity.
• Type 3 vWD is an autosomal recessive disorder characterized by a complete or virtually undetectable absence of vWF (both antigen and activity levels are $<$ 1–5%).
• Because vWF is entirely absent in Type 3 vWD, Factor VIII is unprotected and rapidly degraded, leading to profoundly low secondary Factor VIII levels (often $<$ 5–10%).
• As a result, Type 3 vWD patients suffer from dual hemostatic impairment: severe mucocutaneous bleeds (defective primary hemostasis) as well as spontaneous hemarthroses, deep muscle hematomas, and life-threatening post-surgical hemorrhage mimicking severe hemophilia A.
• Desmopressin (DDAVP) is ineffective in Type 3 vWD due to the complete lack of endothelial storage pools; therefore, treatment strictly requires exogenous vWF/Factor VIII concentrates.
Final Answer:
Type 3 vWD is the most severe subtype of von Willebrand disease due to complete quantitative deficiency of vWF and secondary severe Factor VIII deficiency.